✦ LIBER ✦

Spectrum of disease in U.S. veteran patients with hepatitis C

✍ Scribed by Huy A Nguyen; April I Miller; Eric Dieperink; Mark L Willenbring; Lori L Tetrick; Janet M Durfee; Stephen L Ewing; Samuel B Ho

Book ID: 119392429
Publisher: Nature Publishing Group
Year: 2002
Tongue: English
Weight: 65 KB
Volume: 97
Category: Article
ISSN: 0002-9270
DOI: 10.1016/s0002-9270(02)04156-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment response rates of U.S. veteran

Treatment response rates of U.S. veterans in Brooklyn with chronic hepatitis C infection

✍ Ayse Aytaman; Marna T Abarientos; JoAnn Comas; Anna Christakos-DiTeodoro; Gerald 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 70 KB

Marked reduction in health-related quali

Marked reduction in health-related quality of life in U.S. veterans with chronic hepatitis C

✍ Bini, Edmund J.; Baskies, Michael A.; Mannix, Rosemary A.; Weinshel, Elizabeth H 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 182 KB

Severity of liver disease in patients in

Severity of liver disease in patients infected with different hepatitis C genotypes in the U.S.

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 147 KB

Prevalence of HAV, HBV and HIV coinfecti

Prevalence of HAV, HBV and HIV coinfections among U.S. veterans with chronic hepatitis C

✍ Mihas, Anastasios A.; Arledge, John A.; Lyons, Christopher; Lippman, Robert H.; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 500 KB

589 Hepatic steatosis in patients with c

589 Hepatic steatosis in patients with chronic hepatitis C: a multicenter study of US veterans

✍ Ke-Qin Hu; Ramsey C. Cheung; Sue Currie; Edmund J. Bini; Hui Shen; Bhupinder Ana 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB

Predictors of response of U.S. veterans

Predictors of response of U.S. veterans to treatment for the hepatitis C virus

✍ Lisa I. Backus; Derek B. Boothroyd; Barbara R. Phillips; Larry A. Mole 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB 👁 1 views

The currently recommended treatment for hepatitis C virus (HCV) infection is pegylated interferon alfa (PEG-INF) and ribavirin, which can be difficult to tolerate. More information about predicting sustained virologic response (SVR) may allow more informed treatment decisions to be made. This retros